Suppr超能文献

医护人员中 SARS-CoV-2(COVID-19)特异性抗体的高血清阳性率:伊朗吉兰省的一项横断面研究。

High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran.

机构信息

Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Department of Health, Nutrition & Infectious Diseases, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

出版信息

J Environ Public Health. 2021 Oct 22;2021:9081491. doi: 10.1155/2021/9081491. eCollection 2021.

Abstract

BACKGROUND

This study was conducted to evaluate the anti-SARS-CoV-2 IgM and IgG antibodies among healthcare workers in Guilan.

METHODS

This cross-sectional study was conducted on 503 healthcare workers. Between April and May 2020, blood samples were collected from the healthcare workers of Razi Hospital in Rasht, Guilan, Iran. Enzyme-linked immunosorbent assay (ELISA) was used for the detection and quantitation of anti-SARS-CoV-2 IgM/IgG antibodies by using kits made by Pishtaz Teb Company, Tehran, Iran.

RESULTS

From a total of 503 participants, the result of the anti-SARS-CoV-2 IgM antibody test was positive in 28 subjects (5.6%) and the anti-SARS-CoV-2 IgG antibody test was positive in171 subjects (34%). Participants in the age group of 35-54 years were significantly more likely to have a positive anti-SARS-CoV-2 antibody test than the age group of 20-34 years (odds ratio = 1.53, 95% CI: 1.04-2.25, =0.029). Also, physicians were significantly more likely to have a positive antibody test than office workers (odds ratio = 1.92, 95% CI: 1.04-3.54, =0.037). The wide range of symptoms was significantly associated with the positive anti-SARS-CoV-2 antibody test. The most significant association was observed between fever and a positive anti-SARS-CoV-2 antibody test (odds ratio = 3.03, 95% CI: 2.06-4.44, < 0.001).

CONCLUSION

The results of the current study indicated that the seroprevalence of COVID-19 was high among healthcare workers of Guilan Province. It seems that this finding was due to the earlier exposure to COVID-19 and the lack of awareness and preparedness to deal with the pandemic in Iran, compared to other countries.

摘要

背景

本研究旨在评估伊朗吉兰省医护人员的 SARS-CoV-2 IgM 和 IgG 抗体。

方法

这是一项横断面研究,共纳入 503 名医护人员。2020 年 4 月至 5 月,采集来自伊朗拉什特拉扎医院的医护人员血样。采用酶联免疫吸附试验(ELISA),使用由伊朗德黑兰皮什塔兹泰布公司生产的试剂盒检测并定量 SARS-CoV-2 IgM/IgG 抗体。

结果

在总共 503 名参与者中,28 名(5.6%)的 SARS-CoV-2 IgM 抗体检测结果为阳性,171 名(34%)的 SARS-CoV-2 IgG 抗体检测结果为阳性。与 20-34 岁年龄组相比,35-54 岁年龄组的参与者更有可能 SARS-CoV-2 抗体检测呈阳性(比值比=1.53,95%可信区间:1.04-2.25,=0.029)。此外,与办公室工作人员相比,医生更有可能 SARS-CoV-2 抗体检测呈阳性(比值比=1.92,95%可信区间:1.04-3.54,=0.037)。广泛的症状与 SARS-CoV-2 抗体检测呈阳性显著相关。观察到的最显著相关性是发热与 SARS-CoV-2 抗体检测呈阳性之间的相关性(比值比=3.03,95%可信区间:2.06-4.44, < 0.001)。

结论

本研究结果表明,吉兰省医护人员 COVID-19 的血清流行率较高。与其他国家相比,伊朗可能更早地接触到 COVID-19,并且在应对大流行方面缺乏意识和准备,这可能是造成这种发现的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/188d/8536443/cea8f7dd3ce4/JEPH2021-9081491.001.jpg

相似文献

1
High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran.
J Environ Public Health. 2021 Oct 22;2021:9081491. doi: 10.1155/2021/9081491. eCollection 2021.
4
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
5
SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Front Public Health. 2022 Mar 24;10:832003. doi: 10.3389/fpubh.2022.832003. eCollection 2022.
7
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
Ann Med. 2021 Dec;53(1):1956-1959. doi: 10.1080/07853890.2021.1993325.

引用本文的文献

1
National and sub-national sero-epidemiology of immunoglobulin G against SARS-CoV-2 in Iran in 2021.
PLoS One. 2025 Jul 31;20(7):e0313795. doi: 10.1371/journal.pone.0313795. eCollection 2025.
3
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in HIV-positive and HIV-negative patients in clinical settings in Douala, Cameroon.
Front Epidemiol. 2023 Aug 14;3:1212220. doi: 10.3389/fepid.2023.1212220. eCollection 2023.
4
SARS-CoV-2 Seroprevalence among Health-Care Workers in Isfahan, Iran.
Adv Biomed Res. 2023 Feb 25;12:31. doi: 10.4103/abr.abr_201_21. eCollection 2023.
5
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.
Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022.
9
The Prevalence of COVID-19 Infection in Students and Staff at a Private University in Thailand by Rapid SARS-CoV-2 Antigen Detection Assay.
J Environ Public Health. 2022 Mar 3;2022:2350522. doi: 10.1155/2022/2350522. eCollection 2022.

本文引用的文献

1
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.
Clin Microbiol Infect. 2021 Sep;27(9):1242-1249. doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8.
3
Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review.
PLoS One. 2021 Apr 2;16(4):e0248946. doi: 10.1371/journal.pone.0248946. eCollection 2021.
4
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
Blood Transfus. 2021 May;19(3):181-189. doi: 10.2450/2021.0324-20. Epub 2021 Feb 3.
8
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
9
Point prevalence survey to evaluate the seropositivity for coronavirus disease 2019 (COVID-19) among high-risk healthcare workers.
Infect Control Hosp Epidemiol. 2021 Oct;42(10):1260-1265. doi: 10.1017/ice.2020.1370. Epub 2020 Dec 15.
10
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
Diagn Microbiol Infect Dis. 2021 Mar;99(3):115273. doi: 10.1016/j.diagmicrobio.2020.115273. Epub 2020 Nov 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验